Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prion-Like Characteristics of Polyglutamine-Containing Proteins.

Pearce MMP, Kopito RR.

Cold Spring Harb Perspect Med. 2018 Feb 1;8(2). pii: a024257. doi: 10.1101/cshperspect.a024257. Review.

2.

The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.

Costanzo M, Zurzolo C.

Biochem J. 2013 May 15;452(1):1-17. doi: 10.1042/BJ20121898. Review.

PMID:
23614720
3.

Prion Diseases.

Whitechurch BC, Welton JM, Collins SJ, Lawson VA.

Adv Neurobiol. 2017;15:335-364. doi: 10.1007/978-3-319-57193-5_13. Review.

PMID:
28674988
4.

Role of prion protein aggregation in neurotoxicity.

Corsaro A, Thellung S, Villa V, Nizzari M, Florio T.

Int J Mol Sci. 2012;13(7):8648-69. doi: 10.3390/ijms13078648. Epub 2012 Jul 11. Review.

5.

Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.

Sarnataro D.

Int J Mol Sci. 2018 Oct 9;19(10). pii: E3081. doi: 10.3390/ijms19103081. Review.

6.

The cellular and pathologic prion protein.

Gill AC, Castle AR.

Handb Clin Neurol. 2018;153:21-44. doi: 10.1016/B978-0-444-63945-5.00002-7. Review.

PMID:
29887138
7.

Biology and Genetics of PrP Prion Strains.

Ghaemmaghami S.

Cold Spring Harb Perspect Med. 2017 Aug 1;7(8). pii: a026922. doi: 10.1101/cshperspect.a026922. Review.

PMID:
27920025
8.

Protein aggregation and prionopathies.

Renner M, Melki R.

Pathol Biol (Paris). 2014 Jun;62(3):162-8. doi: 10.1016/j.patbio.2014.01.003. Epub 2014 Mar 31. Review.

PMID:
24698014
9.

Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.

Allison WT, DuVal MG, Nguyen-Phuoc K, Leighton PLA.

Int J Mol Sci. 2017 Oct 24;18(10). pii: E2223. doi: 10.3390/ijms18102223. Review.

10.

Prion-like proteins and their computational identification in proteomes.

Batlle C, Iglesias V, Navarro S, Ventura S.

Expert Rev Proteomics. 2017 Apr;14(4):335-350. doi: 10.1080/14789450.2017.1304214. Epub 2017 Mar 20. Review.

PMID:
28271922
11.
12.

PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Kraus A, Raymond GJ, Race B, Campbell KJ, Hughson AG, Anson KJ, Raymond LD, Caughey B.

J Virol. 2017 Oct 13;91(21). pii: e01276-17. doi: 10.1128/JVI.01276-17. Print 2017 Nov 1.

13.

Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.

Katorcha E, Makarava N, Lee YJ, Lindberg I, Monteiro MJ, Kovacs GG, Baskakov IV.

PLoS Pathog. 2017 Aug 10;13(8):e1006563. doi: 10.1371/journal.ppat.1006563. eCollection 2017 Aug.

14.

In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.

Eraña H, Fernández-Borges N, Elezgarai SR, Harrathi C, Charco JM, Chianini F, Dagleish MP, Ortega G, Millet Ó, Castilla J.

J Virol. 2017 Nov 30;91(24). pii: e01543-17. doi: 10.1128/JVI.01543-17. Print 2017 Dec 15.

15.

Infectious prions and proteinopathies.

Barron RM.

Prion. 2017 Jan 2;11(1):40-47. doi: 10.1080/19336896.2017.1283464.

16.

Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.

Ugalde CL, Finkelstein DI, Lawson VA, Hill AF.

J Neurochem. 2016 Oct;139(2):162-180. doi: 10.1111/jnc.13772. Epub 2016 Sep 15. Review.

17.

Defining the limits: Protein aggregation and toxicity in vivo.

Holmes WM, Klaips CL, Serio TR.

Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):294-303. doi: 10.3109/10409238.2014.914151. Epub 2014 Apr 28. Review.

18.

Peptide-based therapeutic approaches for treatment of the polyglutamine diseases.

Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y.

Curr Med Chem. 2014;21(23):2575-82. Review.

PMID:
24533807
19.

The Unexposed Secrets of Prion Protein Oligomers.

Wang G, Wang M, Li C.

J Mol Neurosci. 2015 Aug;56(4):932-937. doi: 10.1007/s12031-015-0546-1. Epub 2015 Apr 1. Review.

PMID:
25823438
20.

Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.

Eraña H, Venegas V, Moreno J, Castilla J.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1125-1136. doi: 10.1016/j.bbrc.2016.08.166. Epub 2016 Aug 30. Review.

PMID:
27590581

Supplemental Content

Support Center